Pharmacologic treatment of infants with neonatal abstinence syndrome in community hospitals compared to academic medical centers

J Perinatol. 2018 Dec;38(12):1651-1656. doi: 10.1038/s41372-018-0230-8. Epub 2018 Sep 20.

Abstract

Objective: To compare length of hospital stay (LOS), LOS due to neonatal abstinence syndrome (NAS), and duration of pharmacologic treatment in community or academic settings.

Study design: One hundred-two infants exposed to opioids in utero at two community hospitals were compared to 256 from eight academic centers. All infants were managed with non-pharmacologic care followed by similar pharmacologic treatment options.

Results: Two hundred-twelve infants received pharmacologic treatment for NAS. Mean LOS (24.7 ± 8.5 vs. 24.5 ± 11.3 days), LOS due to NAS (24.0 ± 8.2 vs. 23.3 ± 9.2 days), and duration of NAS treatment (19.3 ± 8.0 vs. 18.9 ± 9.2 days) were similar in community compared to academic medical centers.

Conclusions: No significant differences were found in infants managed in the community compared to academic care settings. These findings support caring for opioid-exposed infants in both community and academic settings with the use of standardized care protocols.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Academic Medical Centers / organization & administration*
  • Delivery of Health Care / organization & administration
  • Female
  • Hospitals, Community / organization & administration*
  • Humans
  • Infant
  • Infant, Newborn
  • Length of Stay / statistics & numerical data*
  • Logistic Models
  • Male
  • Neonatal Abstinence Syndrome / drug therapy*
  • Opiate Substitution Treatment
  • Treatment Outcome
  • United States